Products of cyclooxygenase-2 depress duodenal function in rats subjected to abdominal surgery

Acta Physiologica

Volumn 186, Issue 4, 2006, Pages 279-290

  Pihl, L ^a   Nylander, O ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Bicarbonate secretion; Motility; Mucosal permeability; Post operative ileus

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; BICARBONATE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; HYPERTONIC SOLUTION; INDOMETACIN; ISOTONIC SOLUTION; PARECOXIB; PROSTAGLANDIN SYNTHASE INHIBITOR; PROSTANOID; ROFECOXIB; SODIUM CHLORIDE; THIOBUTABARBITAL;

ABDOMINAL SURGERY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUODENUM; GASTROINTESTINAL TRACT FUNCTION; ILEUS; INTESTINE; INTESTINE MOTILITY; INTESTINE MUCOSA PERMEABILITY; MALE; NONHUMAN; OSMOLALITY; PRIORITY JOURNAL; RAT; SYNTHESIS;

ANIMALS; BICARBONATES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DUODENUM; GASTROINTESTINAL MOTILITY; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; ISOXAZOLES; LACTONES; LAPAROTOMY; MALE; OSMOLAR CONCENTRATION; PERFUSION; PYRAZOLES; RATS; RATS, INBRED LEW; SODIUM CHLORIDE; SULFONES;

EID: 33645718360     PISSN: 17481708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2006.01559.x     Document Type: Article

References (35)

1. Axelsson L.-G. Wallin B. Gillberg P.-G. Sjöberg B. Söderberg C. Hellström P.M. 2003. Regulatory role of 5-HT and muscarinic receptor antagonists on the migrating myoelectric complex in rats. Eur J Pharmacol 467 211 218.
2. Bauer A.J. Boeckxstaens G.E. 2004. Mechanisms of postoperative ileus. Neurogastroenterol Motil 16 54 60.
3. Bazan N.G. 2001. COX-2 as a multifunctional neuronal modulator. Nat Med 7 414 415.
4. Behm B. Stollman N. 2003. Postoperative ileus: etiologies and interventions. Clin Gastroenterol Hepatol 1 71 80.
5. Bouras E.P. Burton D.D. Camilleri M. Stephens D.A. Thomforde G.M. 2004. Effect of cyclooxygenase-2 inhibitors on gastric emptying and small intestine transit in humans. Neurogastroenterol Motil 16 729 735.
6. Bueno L. Ferre J.P. Ruckebusch Y. 1978. Effects of anesthesia and surgical procedures in intestinal myoelectric activity in rats. Am Dig Dis 23 690 695.
7. Cao Y. Prescott S.M. 2002. Many action of cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol 190 279 286.
8. Chan C.C. Boyce S. Brideau C. et al. 1999. Rofecoxib [Vioxx, MK-0966; 4-(4′-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. Pharmacol Exp Ther 290 551 560.
9. Hällgren A. 1997. Duodenal mucosal permeability, bicarbonate secretion and motility. Upsala J Med Sci 102 137 174.
10. Haworth R. Oakley K. McCormack N. Pilling A. 2005. Differential expression of COX-1 and COX-2 in the gastrointestinal tract of the rat. Toxicol Pathol 33 239 245.
11. Husebye E. 1999. The patterns of small bowel motility: physiology and implication in organic disease and functional disorders. Neurogastroenterol Motil 11 141 161.
12. Ito S. Okuda-Ashitaka E. Minami T. 2001. Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin. Neurosci Res 41 299 332.
13. Kalff J.C. Turler A. Schwarz N.T. Schraut W.H. Lee K.K. Tweardy D.J. Billiar T.R. Simmons R.L. Bauer A.J. 2003. Intra-abdominal activation of a local inflammatory response within the human muscularis externa during laparotomy. Ann Surg 237 301 315.
14. Kargman S. Charleson S. Cartwright M. Frank J. Riendeau D. Mancini J. Evans J. O'Neill G. 1996. Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology 111 445 454.
15. Kato M. Nishida S. Kitasato H. Sakata N. Kawai S. 2001. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroid anti-inflammatory drugs: investigation using human peripheral monocytes. J Pharm Pharmacol 53 1679 1685.
16. Kreiss C. Birder L.A. Kiss S. VanBibber M.M. Bauer A.J. 2003. COX-2 dependent inflammation increases spinal Fos expression during rodent postoperative ileus. Gut 52 527 534.
17. Marik P.E. Zaloga G.P. 2002. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 122 1784 1796.
18. Maubach K.A. Grundy D. 1999. The role of prostaglandins in the bradykinin-induced activation of serosal afferents of the rat jejunum in vitro. J Physiol 515 277 285.
19. Menger M.D. Vollmar B. 2004. Surgical trauma: hyperinflammation versus immunosuppression. Langenbecks Arch Surg 389 475 484.
20. Nylander O. Hällgren A. Sababi M. 2001. COX inhibition excites enteric nerves that affect motility, alkaline secretion, and permeability in rat duodenum. Am J Physiol Gastrointest Liver Physiol 281 G1169 G1178.
21. Nylander O. Pihl L. Perry M. 2003. The hypotonicity-induced increase in duodenal mucosal permeability facilitates adjustment of luminal osmolality. Am J Physiol Gastrointest Liver Physiol 285 G360 G370.
22. Padi S.S.V. Jain N.K. Singh S. Kulkarni S.K. 2004. Pharmacological profile of parecoxib: a novel, potent injectable selective cyclooxygenase-2 inhibitor. Eur J Pharmacol 491 69 76.
23. Pairet M. Ruckebusch Y. 1989. On the relevance of non-steroidal anti-inflammatory drugs in the prevention of paralytic ileus in rodents. J Pharm Pharmacol 41 757 761.
24. Sababi M. Nylander O. 1994. Elevation of intraluminal pressure and cyclooxygenase inhibitors increases duodenal alkaline secretion. Am J Physiol Gastrointest Liver Physiol 266 G22 G30.
25. Sababi M. Hällgren A. Nylander O. 1996. Interaction between prostanoids, NO, and VIP in modulation of duodenal alkaline secretion and motility. Am J Physiol Gastrointest Liver Physiol 271 G582 G590.
26. Schwarz N.T. Kalff J.C. Türler A. Engel B.M. Watkins S.C. Billiar T.R. Bauer A.J. 2001. Prostanoid production via COX-2 as a causative mechanism of rodent postoperative ileus. Gastroenterology 121 1354 1371.
27. Sheeran P. Hall G.M. 1997. Cytokines in anaesthesia. Br J Anaesth 78 201 219.
28. Sigthorsson G. Simpson R.J. Walley M. Anthony A. Foster R. Hotz-Behoftsitz C. Palizban A. Pombo J. Watts J. Morham S.G. Bjarnason I. 2002. COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice. Gastroenterology 122 1913 1923.
29. Smith C.J. Zhang Y. Koboldt C.M. Muhammad J. Zweifel B.S. Shaffer A. Talley J.J. Masferrer J.L. Seibert K. Isakson P.C. 1998. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci 95 13313 13318.
30. Takeuchi K. Kagawa S. Mimaki H. Aoi M. Kawauchi S. 2002. COX and NOS isoforms involved in acid-induced duodenal bicarbonate secretion in rats. Dig Dis Sci 47 2116 2124.
31. Tanaka A. Hase S. Miyazawa T. Ohno R. Takeuchi K. 2002. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroid anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events. J Pharmacol Exp Ther 303 1248 1254.
32. Teng X.W. Abu-Mellal A.K. Davies N.M. 2003. Formulation dependent pharmacokinetics, bioavailability and renal toxicity of a selective cyclooxygenase-1 inhibitor SC-560 in the rat. J Pharm Pharm Sci 6 205 210.
33. Vane J.R. Bakhla Y.S. Botting R.M. 1998. Cyclooxygenase 1 and 2. Annu Rev Pharmacol Toxicol 38 97 120.
34. Warner T.D. Mitchell J.A. 2004. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J 18 790 804.
35. Zha S. Yegnasubramanian V. Nelson W.G. Isaacs W.B. De Marzo A.M. 2004. Cyclooxygenases in cancer: progress and perspective. Cancer Lett 215 1 20.